申请人:FUJIREBIO Inc.
公开号:EP0520336A2
公开(公告)日:1992-12-30
Aldehyde derivatives with a specific calpain inhibiting activity and a platelet-aggregation inhibiting effect with formula (I) or formula (II):
wherein R1 represents an aromatic hydrocarbon group, a heterocyclic group, or a group of -X-R3 in which X represents O, -S(O)m- (m = 0, 1, or 2), and R3 represents an aromatic hydrocarbon group, a heterocyclic group, or an alkyl group; Z represents R4-Y- or R60-CH(R5)- in which Y represents a 3- to 7-membered nitrogen-containing saturated heterocyclic group, or a single cyclic saturated hydrocarbon group, R4 represents an alkyl group, an alkenyl group, an alkynyl group, an acyl group, a sulfonyl group, an alkoxycarbonyl group, a carbamoyl group, or a thiocarbamoyl group, R5 represents hydrogen, an alkyl group, or an aromatic hydrocarbon group, and R6 represents an acyl group, a carbamoyl group, a thiocarbamoyl group, or an alkyl group; and n is an integer of 1 to 5.
wherein R7, R8, R9, and R10 are defined in the specification.
具有特异性钙蛋白酶抑制活性和血小板聚集抑制作用的式 (I) 或式 (II) 醛衍生物:
其中 R1 代表芳香烃基团、杂环基团或-X-R3 的基团,其中 X 代表 O、-S(O)m- (m = 0、1 或 2),R3 代表芳香烃基团、杂环基团或烷基;Z 代表 R4-Y- 或 R60-CH(R5)-,其中 Y 代表 3 至 7 元含氮饱和杂环基团,或单环饱和烃基团,R4 代表烷基、烯基、炔基、酰基、磺酰基、烷基、炔基或烷基R5 代表氢、烷基或芳香烃基,R6 代表酰基、氨基甲酰基、硫代氨基甲酰基或烷基;n 是 1 至 5 的整数。
其中 R7、R8、R9 和 R10 的定义见说明书。